Year | Title of POEM | Reference |
---|---|---|
1998 | Metformin is best for obese patients with type 2 diabetes mellitus | UK Prospective Diabetes Study Group10 |
1999 | β-Blockers are effective in heart failure | Lechat P, et al11 |
2000 | 3 Years between Papanicolaou tests are adequate for many women | Sawaya GF, et al12 |
2001 | Managing heart rate and rhythm are similar for atrial fibrillation | Hohnloser SH, et al13 |
2002 | Hormone replacement overall is not beneficial | Writing Group for the Women’s Health Initiative Investigators14 |
2003 | Self-breast examination does not reduce mortality | Thomas DB, et al15 |
2004 | Breast cancer screening results in overdiagnosis | Zahl P, et al16 |
2005 | Vaccine prevents human papillomavirus infection | Harper DM, et al17 |
2006 | Delayed prescription for acute otitis media reduces unnecessary antibiotics | Spiro DM, et al18 |
2007 | Home blood glucose monitoring is ineffective for type 2 diabetes mellitus | Farmer A, et al19 |
2008 | Intensive control of blood glucose in type 2 diabetes mellitus may be harmful | Gerstein HC, et al20 |
2009 | Prostate-specific antigen screening does not reduce mortality from prostate cancer | Andriole GL, et al21 |
2010 | Statin + fenofibrate is no better than statin alone in type 2 diabetes mellitus | The ACCORD Study Group22 |
2011 | Rivaroxaban is similar to warfarin for patients with nonvalvular atrial fibrillation | Patel MR, et al23 |
2012 | Conservative therapy with antibiotics is an option for early uncomplicated acute appendicitis | Varadhan KK, et al24 |
2013 | Fasting is not necessary before measuring lipid panels | Sidhu D and Naugler C25 |
2014 | Niacin does not improve clinical outcomes in patients with vascular disease | The HPS2-THRIVE Collaborative Group, Landray MJ, et al26 |
2015 | Steroids are beneficial as adjunctive treatment for community-acquired pneumonia | Siemieniuk RAC, et al27 |
2016 | Active surveillance for localized prostate cancer: no increased mortality, but higher rates of clinical progression | Hamdy FC, et al28 |
2017 | Semaglutide reduces cardiovascular events in high-risk patients with type 2 diabetes mellitus | Marso SP, et al29 |
POEM = patient-oriented evidence that matters.